Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 43

  1. Cat.No. Product Name Information/Activity
  2. BCC7228 Ro 19-4603 99632-94-7 Ro 19-4603 chemical structure
  3. BCC6087 TCS 1105 185391-33-7 TCS 1105 chemical structure
  4. BCC5197 Zaleplon 151319-34-5 Zaleplon chemical structure
  5. BCC7227 ZK 93423 hydrochloride Potent benzodiazepine agonist ZK 93423 hydrochloride chemical structure
  6. BCC7229 ZK 93426 hydrochloride 1216792-30-1 ZK 93426 hydrochloride chemical structure
  7. BCC7829 AA 29504 Positive allosteric modulator of GABA<sub>A</sub> receptors AA 29504 chemical structure
  8. BCC7737 Allopregnanolone GABA<sub>A</sub> receptor positive allosteric modulator Allopregnanolone chemical structure
  9. BCC7545 Alphaxalone 23930-19-0 Alphaxalone chemical structure
  10. BCC6830 Chlormethiazole hydrochloride 6001-74-7 Chlormethiazole hydrochloride chemical structure
  11. BCC7748 DS2 374084-31-8 DS2 chemical structure

Items 421 to 430 of 709 total